CBIO – crescent biopharma, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

CBIO

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

12/4

05:03 pm

cbio

Crescent Biopharma (NASDAQ:CBIO) was given a new $32.00 price target on by analysts at Stifel Nicolaus.

Low Report

Crescent Biopharma (NASDAQ:CBIO) was given a new $32.00 price target on by analysts at Stifel Nicolaus.

Report

11/25

01:49 pm

cbio

Crescent Biopharma (NASDAQ:CBIO) had its "sell (e-)" rating reaffirmed by analysts at Weiss Ratings.

Low Report

Crescent Biopharma (NASDAQ:CBIO) had its "sell (e-)" rating reaffirmed by analysts at Weiss Ratings.

Report

11/19

01:17 pm

cbio

Crescent Biopharma (NASDAQ:CBIO) had its "sell (e-)" rating reaffirmed by analysts at Weiss Ratings.

Low Report

Crescent Biopharma (NASDAQ:CBIO) had its "sell (e-)" rating reaffirmed by analysts at Weiss Ratings.

Report

11/16

01:09 am

cbio

Crescent Biopharma (NASDAQ:CBIO) was upgraded by analysts at Wall Street

Low Report

Crescent Biopharma (NASDAQ:CBIO) was upgraded by analysts at Wall Street

Report

11/13

01:25 pm

cbio

Crescent Biopharma (NASDAQ:CBIO) is now covered by analysts at Weiss Ratings. They set a "sell (e-)" rating on the stock.

Low Report

Crescent Biopharma (NASDAQ:CBIO) is now covered by analysts at Weiss Ratings. They set a "sell (e-)" rating on the stock.

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.